Roth Pharma

At Roth Pharma,  we are positioning ourselves for complete vertical integration in Africa with a focus on medicinal cannabinoids and pharmaceutical-grade cannabis. This comprises of Licensing, Land acquisition, Cultivation, Staffing, Extraction, Distillation

Profiling of cannabinoids and terpenoids that fit medical conditions. Preventative, curative, management.

Focussed on  R&D Clinical Trials through our extensive in-house and partner labs.  Strong relations with universities globally.

OUR CORE PILLARS

Our Competitive Advantage 

Roth Pharma have demonstrated a growing concentration rate on our cannabidiol (CBD) product of 26.4% as opposed to the original content of CBD in cannabis S. 0.45%

This translates to 70% less in costs

  • Land
  • Water
  • Staff
  • Equipment

Or a 70% increase in profits – Better product at a lower price

Medicinal Cannabinoids

the active chemicals in medical marijuana — are similar to chemicals the body makes that are involved in appetite, memory, movement, and pain. – WebMD

Clinical Data0%
Research Data0%
Agronomy Data0%

Mission

At Roth Pharma we aim at becoming the “Go-To” company for pharmaceutical grade cannabis in Africa for pharmaceutical companies, biotech companies, and retail pharmacies globally

Medical Cannabis in Africa - Roth Pharma

Research and Development

We want the answers to medical conditions. The right Medicinal Cannabinoids to prevent, treat and manage medical conditions

TB

efficacy, accessibility and affordability with cannabis derivativesin combination with two other substances, (cannabinoid/terpenoid, TBA profile, physiological, pharmacokinetics, pharmacological and clinical evaluation. Conclusive Prelim Cell Invitro studies

Respiratory Infections

efficacy, accessibility and affordability with cannabis derivatives(cannabinoid/terpenoid, TBA profile, , physiological, pharmacokinetics, pharmacological and clinical evaluation.

Epilepsy

Refractory epilepsy (LGS) (SMEI-DS) efficacy, accessibility and affordability with cannabis derivates, (cannabinoid/terpenoid profile) evaluating bioavailability (liposome/nano). fMRI. Physiological, pharmacokinetics, pharmacological and clinical evaluation.

Alzheimer

efficacy, accessibility and affordability with cannabis derivativesin combination with other substances, (cannabinoid/terpenoid, TBA profile, physiological, pharmacokinetics, pharmacological and clinical evaluation.

Diabetes

efficacy, accessibility and affordability with cannabis derivatives(cannabinoid/terpenoid, TBA profile, physiological, pharmacokinetics, pharmacological and clinical evaluation.

Fibromyalgia

efficacy, accessibility and affordability with cannabis derivatives(cannabinoid/terpenoid, TBA profile, physiological, pharmacokinetics, pharmacological and clinical evaluation.

Cancer

efficacy, accessibility and affordability with cannabis derivatives(cannabinoid/terpenoid, TBA profile, physiological, pharmacokinetics, pharmacological and clinical evaluation. Positive conclusive Invitro studies..

Reproduction

efficacy, accessibility and affordability with cannabis derivatives(cannabinoid/terpenoid, TBA profile, , physiological, pharmacokinetics, pharmacological and clinical evaluation.

Malaria

efficacy, accessibility and affordability with cannabis derivatives(cannabinoid/terpenoid, TBA profile, physiological, pharmacokinetics, pharmacological and clinical evaluation.

HIV

efficacy, accessibility and affordability with cannabis derivatives(cannabinoid/terpenoid, TBA profile, physiological, pharmacokinetics, pharmacological and clinical evaluation.

Opioids

Focus on the effects of narcotics on physiological regulatory mechanisms of both the BTB and BBB, in particular, the effects of Cannabis, examining the effects of these narcotics on permeability across in vitro models of the BTB and BBB, rates of cell growth, morphology (HRSEM, HRTEM and fluorescence), viability, toxicology, mitochondrial function, apoptosis, ROS and ATP production, protein expression (PCR and Western blotting), etc., on the primary cellular components/cell lines of the BTB and BBB.

Patent Registration

Conclusive results have led to a ground breaking patent registration (Details under NDA)

Digital Pharma Leads

Roth Pharma is partnered with a US Pharma marketing company that specializes in medicinal cannabinoids for prescription pain management and diabetes mainly. They own a chain of Pharmacies within the USA.

Roth Pharma have taken the gaming model of affiliate marketing and implemented into Pharmaceuticals. We have a network of affiliates supplying opt-in traffic in accordance with the HIIPPA legislation. Pharma companies can market specific products through us and we will generate privately insured patients to them. We have given pharmaceutical companies the ability to know exactly how many customers their dollars are buying and the ROI.

SEO

We currently have a strategic plan with a top-level SEO agency to develop content and SEO for the Pharma and Medical cannabis models that will generate opt-in patients.

LEADS

We have the ability to generate 300 Pharma leads per day that go through to our call center for triage and then directly on to our Teledoc partners for prescriptions. We deliver the medication to the patient and we provide refill management.

FUNNELS

We use full funnel conversion tactics to optimise Cost per patient. Outbound Calling and SMS are most successful.

Our research and development team at Roth Pharma wants the answers to medical conditions with cannabis derivatives. The right pharmaceutical-grade cannabis  to prevent, treat and manage medical conditions